You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 4, April 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ophthalmological Disorders, Other
 •World Health
 •Alert me on articles by topic

VISION 2020: The Right to Sight

A Global Initiative to Eliminate Avoidable Blindness

Louis Pizzarello, MD; Adenike Abiose, FRCOphth; Timothy Ffytche, FRCOphth; Rainaldo Duerksen, MD; R. Thulasiraj, MBA; Hugh Taylor, MD; Hannah Faal, FRCOphth; Gullapali Rao, MD; Ivo Kocur, MD; Serge Resnikoff, MD

Arch Ophthalmol. 2004;122:615-620.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

An estimated 45 million people around the world are blind.1 Most of them have lost their sight to diseases that are treatable or preventable. Eighty percent of them live in the lesser-developed world in countries where chronic economic deprivation is exacerbated by the added challenge of failing vision. Without intervention, the number of individuals with blindness might reach 76 million by 2020 because of a number of factors, primarily the rapid aging of populations in most countries.2 Since eye disease is seen largely in older people, the projected doubling of the world's population older than 50 years to 2 billion by 2020 has profound effects on the number of those with blindness and low vision.

In response to this global . . . [Full Text of this Article]

THE IAPB

NATIONAL PROGRAMS AND PLANS OF ACTION

REGIONAL REPORTS

Africa

Eastern Mediterranean

Europe

North America

South America

Southeast Asia

Western Pacific

COST EFFECTIVENESS OF VISION 2020

GLOBAL COMMITMENT

RESOLUTION OF THE WORLD HEALTH ASSEMBLY

From the International Agency for the Prevention of Blindness, London, England (Drs Pizzarello, Abiose, Ffytche, Duerksen, Taylor, Faal, and Rao and Mr Thulasiraj); the Centre for Eye Research, Columbia University, New York, NY (Dr Pizzarello); University of Melbourne, Melbourne, Australia (Dr Taylor); and the World Health Organization, Program for Prevention of Blindness and Deafness, Geneva, Switzerland (Drs Kocur and Resnikoff).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinoblastoma: One World, One Vision
Rodriguez-Galindo et al.
Pediatrics 2008;122:e763-e770.
ABSTRACT | FULL TEXT  

Prevalence and causes of blindness and visual impairment in Limbe urban area, South West Province, Cameroon
Oye and Kuper
Br. J. Ophthalmol. 2007;91:1435-1439.
ABSTRACT | FULL TEXT  

In Vitro Generation of Functional Lens-Like Structures with Relevance to Age-Related Nuclear Cataract
O'Connor and McAvoy
IOVS 2007;48:1245-1252.
ABSTRACT | FULL TEXT  

Uncorrected refractive error
McCarty
Br. J. Ophthalmol. 2006;90:521-522.
FULL TEXT  

The social and family dynamics behind the uptake of cataract surgery: findings from Kilimanjaro Region, Tanzania
Geneau et al.
Br. J. Ophthalmol. 2005;89:1399-1402.
ABSTRACT | FULL TEXT  

Microarray Analysis of the Failure of Filtering Blebs in a Rat Model of Glaucoma Filtering Surgery
Esson et al.
IOVS 2004;45:4450-4462.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.